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Postoperative neurocognitive disorders are common complications in elderly patients 
following surgery or critical illness. High mobility group box 1 protein (HMGB1) is rapidly 
released after tissue trauma and critically involved in response to sterile injury. Herein, we 
assessed the role of HMGB1 after liver surgery in aged rats and explored the therapeutic 
potential of a neutralizing anti-HMGB1 monoclonal antibody in a clinically relevant model 
of postoperative neurocognitive disorders. Nineteen to twenty-two months Sprague-
Dawley rats were randomly assigned as: (1) control with saline; (2) surgery, a partial 
hepatolobectomy under sevoflurane anesthesia and analgesia, + immunoglobulin G as 
control antibody; (3) surgery +  anti-HMGB1. A separate cohort of animals was used 
to detect His-tagged HMGB1 in the brain. Systemic anti-HMGB1 antibody treatment 
exerted neuroprotective effects preventing postoperative memory deficits and anxiety 
in aged rats by preventing surgery-induced reduction of phosphorylated cyclic AMP 
response element-binding protein in the hippocampus. Although no evident changes 
in the intracellular distribution of HMGB1 in hippocampal cells were noted after surgery, 
HMGB1 levels were elevated on day 3 in rat plasma samples. Experiments with tagged 
HMGB1 further revealed a critical role of systemic HMGB1 to enable an access to the 
brain and causing microglial activation. Overall, these data demonstrate a pivotal role for 
systemic HMGB1 in mediating postoperative neuroinflammation. This may have direct 
implications for common postoperative complications like delirium and postoperative 
cognitive dysfunction.
Keywords: aging, hMgB1, inflammation, memory, microglia, surgery
inTrODUcTiOn
Postoperative neurocognitive disorders, encompassing postoperative delirium (POD) and postop-
erative cognitive dysfunction (POCD), are common complications in elderly patients over 65 years 
of age following surgery or critical illness (1). Up to 47% of elderly patients experience cognitive dys-
function at hospital discharge and about 10% retain persistent cognitive deficits 3 months after major 
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surgery (2). Occurrence of these postoperative complications 
significantly associate with increased morbidity and mortality, 
greater length of hospital stay, increased costs, and decreased life 
independence (3). These outcomes, combined with the constant 
increase in the geriatric population, render postoperative neuro-
cognitive disorders a significant complication that currently lacks 
defined mechanisms and treatments.
It is well appreciated that sterile injury, including surgical 
trauma, triggers a milieu of factors that ultimately contribute to 
the inflammatory process (4). Damage-associated molecular pat-
tern molecules (DAMPs), in particular high mobility group box 
1 (HMGB1), are rapidly released after tissue trauma and mediate 
immune cell recruitment and activation, cytokine release, and cell 
death (5). This molecule is highly preserved through evolution 
and is 99% identical between mammals (6). HMGB1 release has 
been described in preclinical models of cognitive decline (7–9). 
However, its contribution to postoperative neuroinflammation 
remains unclear. Increased levels of HMGB1 after surgery have 
been related to compromising the blood–brain barrier (BBB) 
and subsequent neuroinflammation (10, 11). Recently, changes 
in serum HMGB1 and other pro-inflammatory cytokines were 
positively associated with human POCD after gastrointestinal 
surgery in elderly patients (12).
Based on the above, we assessed the role of HMGB1 after 
liver surgery in aged rats and the therapeutic potential of a neu-
tralizing anti-HMGB1 monoclonal antibody (mAb) as a mean 
to prevent postoperative neurocognitive disorders. Herein, we 
show a prominent role for systemic HMGB1 signaling to medi-
ate neuroinflammation and neurotoxicity. Anti-HMGB1 mAb 
treatment increased phosphorylation of cyclic AMP response 
element binding (p-CREB) in the hippocampus after surgery, 
suggesting that anti-HMGB1 exerts neuroprotective effects in 
aged rats. These effects on neuroinflammation and synaptic 
plasticity may inform on pathophysiological mechanisms of 
delirium and other postoperative neurocognitive disorders 
appearing after surgery.
MaTerials anD MeThODs
animals
Experiments were performed in accordance with the guidelines 
for experimental animal use of the Central South University. The 
protocol [LLSC(LA)2015-003] was approved by the ethics com-
mittee of the third Xiangya Hospital of Central South University. 
Aged female Sprague-Dawley (SD) rats (19–22  months, 450–
600 g) were purchased from Central South University (China). 
Rats had surgery in the diestrus phase when estrogen levels are at 
their minimum. All rats were housed in standard cages with free 
access to food and water.
Drug administration
Aged rats were randomly divided into 3 groups: (1) control with 
intravenous (i.v.) saline only; (2) surgery  +  immunoglobulin 
(IgG) (S  +  IgG) (1  mg/kg i.v.); (3) surgery  +  anti-HMGB1 
(S + anti-HMGB1) (1 mg/kg i.v.). Treatments were given via tail 
vein immediately before surgical incision and 6 h after surgery; 
dosage and timing was based on Okuma et al. (13). Anti-HMGB1 
antibody (2G7, mouse IgG2b) was supplied by Dr. H.E. Harris’s 
laboratory, Stockholm, Sweden. This antibody has been exten-
sively characterized previously with respect to its HMGB1 neu-
tralizing activity in in vitro and in vivo studies (9, 14–18). The 2G7 
anti-HMGB1 mAb neutralizes both HMGB1-induced cytokine/
chemokine release and chemotactic activities. Mouse IgG2b 
(Sigma, M1395-5MG) was used as an isotype control. A separate 
cohort of rats was divided into 4 groups: (1) control saline alone; 
(2) surgery with saline; (3) surgery with Histidine (His)-tagged 
HMGB1 (1 mg/kg); (4) His-tagged HMGB1 only (1 mg/kg). His-
tagged HMGB1 (Sigma, cat. Number 4652) or saline was given 
via tail vein right before surgical incision.
Partial hepatolobectomy
Rats were rapidly induced with 5% sevoflurane anesthesia 
(Maruishi Pharmaceutical Co., Ltd., Japan) with high flow of 
oxygen (6  L/min). As each rat achieved loss of righting reflex, 
it was intubated with a 14G catheter and anesthesia maintained 
with continuous delivery of 3.5–4.5% sevoflurane mixed with 
oxygen (80–85%). The gas was monitored and analyzed by a 
multi-function monitor (Datex-Ohmeda, Helsinki, Finland); 
respiratory rate (R), PetCO2, FiO2, and FiSev were continuously 
recorded. The depth of anesthesia was modulated according 
to the R (30–50/min) and the body movement of the rats. The 
partial hepatolobectomy was performed as previously described 
with some modifications (19). Briefly, an incision about 2 cm long 
was made below the xyphoid; the left lobe of liver was carefully 
isolated, ligated, and then removed. Finally, muscles and skin 
were closed with sterile sutures and subcutaneous tissue infiltra-
tion with 0.2 mL of 0.25% bupivacaine was administered for the 
purpose of local postoperative analgesia. Animals were then 
allowed to recover for further testing.
Behavioral Tests
Barnes Maze
Rats were tested with a protocol previously described (20). Briefly, 
rats were trained to locate the escaping hole on a Barnes maze 
four times/day on postoperative days 1–4 (3 min/trial and 15 min 
between each trial). The number of incorrect hole investigation 
(termed error) during each trial were recorded. The platform 
surface was cleaned with 75% ethanol before each trial in order 
to remove odor cues.
Open Field
Open field test was used to evaluate the anxiety level of the 
animal. A rat was placed directly into the center of the open field 
(100 cm × 100 cm × 48 cm, length × width × height). Movement 
of the rat in the open field was recorded by a digital camera during 
the 5-min testing session. The total square crossings, time spent 
in the central area and the percentage of square crossings in the 
central area to the total square crossings, were counted.
immunostaining
Rats were terminated with chloral hydrate (10%) and perfused 
transcardially with ice cold 0.01M phosphate-buffered saline 
TaBle 1 | list of antibodies used in the study.
antibody host antigen supplier/cat. 
num.
concentration 
HMGB1 Rabbit/monoclonal Synthetic peptide corresponding to Human HMGB1 aa 150 to the C-terminus Abcam, ab79823 1:1000
p-CREB Rabbit/monoclonal Synthetic phoshopeptide corresponding to residues surrounding Serine 133 of human CREB Abcam, ab32096 1:1000
Iba1 Rabbit/polyclonal Synthetic peptide corresponding to C-terminus of Iba1 Wako, 019-19741 1:1000
NR2A Rabbit/monoclonal Synthetic peptide corresponding to Human NMDAR2A Epitomics, 3916-1 1:2000
NR2B Rabbit/polyclonal Synthetic peptide conjugated to KLH derived from within residues 1450 to the C-terminus of 
Rat NMDAR2B
Abcam, ab65783 1:1000
His Mouse/monoclonal Sigma, H1029 1:5000
GAPDH Rabbit/polyclonal full-length GAPDH of human origin Proteintech, 
10494-1-AP
1:2000
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(PBS). The brain was rapidly dissected; one hemisphere was 
used for immunostaining and the other for western blot. The 
hemisphere used for immunostaining was postfixed in 4% 
paraformaldehyde overnight at 4°C. After dehydrating with 15% 
and 30% sucrose, the brains were embedded in OCT (SAKURA 
Tissue-Tek, USA), and cryostat transverse sections of the brain 
(20 μm) were obtained. Four sections of hippocampus were ran-
domly picked from 4 sets of serial sections from each rat at −3.6 
to −4.16 mm anteroposterior to the bregma for immunostaining. 
Sections were washed three times in 0.01M PBS and incubated in 
3% H2O2 for 10 min. After three washes, sections were blocked 
with 5% BSA in 0.01M PBS plus 0.1% Triton X-100 for 1  h at 
room temperature and then incubated with primary antibodies 
(1:1000, Iba-1, HMGB1, p-CREB) at 4°C overnight. Full details 
on the antibodies used are presented in Table 1. After washing 
three times in 0.01M PBS, the sections were incubated with 
secondary antibodies (Biotinylated Goat Anti-Rabbit IgG, 1:200, 
Vector, USA) for 1 h at room temperature, subsequently washed 
three times in 0.01M PBS and finally covered with permount 
containing DAPI (Vector, USA, H-1200). For each staining, pic-
tures of Cornu Ammonis (CA)1 and Dentate Gyrus (DG) areas 
were taken under the same magnification (40× objective lens) 
and constant light intensity with a microscope (DS-Ri1, Nikon, 
Japan) by an author blinded to treatments.
Western Blot
Western blotting was used to assess the expression of N-methyl-
d-aspartate receptor (NMDAR) subunits NR2A and NR2B, 
HMGB1, and GAPDH in the hippocampus. Briefly, frozen hip-
pocampus was homogenized in lysis buffer containing protease 
inhibitors cocktails (Roche, Germany, cat num P8340) and phe-
nylmethanesulfonylfluoride (PMSF, Sigma, USA, cat num p7626). 
The quantity of protein of samples was determined using a BCA 
protein assay kit (CWBio, China) according to the manufacturer’s 
instructions. Equal amounts of protein samples were separated by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to polyvinylidene fluoride membranes. 
Membranes were blocked with 10% skim milk in TBST buffer 
for 1  h and then incubated with primary antibodies, HMGB1 
(1:1000 Abcam, USA), NR2A (1:2000 Epitomics, USA), NR2B 
(1:1000 Abcam, USA), GAPDH (1:2000 Proteintech, China), and 
GAPDH (1:2000 Proteintech, China), anti-His antibody (1:5000 
Sigma) overnight at 4°C (Table 1). After three washes, membranes 
were incubated with the secondary antibodies (Goat Anti-Rabbit 
IgG, HRP Conjugated, 1:2000, CWBIO, China, catalog number 
CW0103, Goat Anti-Mouse IgG, HRP Conjugated, 1:2000, 
CWBIO, China, catalog number CW0102) at room temperature 
for 2 h. Finally, visualization of the proteins was accomplished 
by enhanced chemiluminescence detection kit (Pierce; Thermo 
Scientific, Shanghai, China), and the intensity of each band was 
quantified by densitometry. Relative expression levels of protein 
were normalized by the ratio of target protein (HMGB1, NR2A, 
and NR2B) to GAPDH.
enzyme-linked immunosorbent assay
Under anesthesia, blood was collected from the right auricle in 
EDTA coated tubes and then centrifuged for 10 min at 3000 rpm. 
Plasma was collected and frozen at −80°C for further analyses. 
Human plasma was collected under an approved protocol by the 
Ethics Committee of the Third Xiangya Hospital of Central South 
University (protocol number: 2015-S165). Six patients identified 
with POD by The Confusion Assessment Method (CAM) (21) 
daily testing were compared to age-matched surgical controls 
(non-delirious). Blood was centrifuged at 3000 rpm for 10 min 
at room temperature, and the plasma samples were immediately 
frozen at −80°C. Concentration of HMGB1 in plasma was meas-
ured using ELISA (IBL International, Germany, catalog number 
ST51011) according to the manufacturer’s protocol.
statistical analysis
Data are shown as mean ±  SEM. Two-way repeated measures 
ANOVA was used to analyze the data from Barnes Maze test. 
ANOVA was used to analyze the data from open field test, Western 
blot, and immunostaining. Bonferroni Multiple Comparison Test 
was performed to compare selected groups when ANOVA showed 
significance. Statistical analysis was performed using Prism 5 
(Graph Pad Software Inc., La Jolla, CA, USA). Significance was 
set at p < 0.05.
resUlTs
Blocking hMgB1 improves Postoperative 
cognitive Decline and anxiety  
in aged rats
All rats were included in the study protocol, and no mortality 
was reported after the surgical procedure. We evaluated learning 
FigUre 1 | anti-hMgB1 improves memory dysfunction and anxiety in aged rats. Spatial memory was evaluated in the Barnes maze. Rats that had 
undergone liver surgery had significant memory impairments as detected by error numbers in reaching the correct target box (a). Treatment with anti-HMGB1 mAb 
significantly improved postoperative memory dysfunction on both days 2 and 3 after surgery. (B) Anxiety was measured in an open field on postoperative day 3. 
Treatment with anti-HMGB1 mAb prevented postoperative anxiety as compared to the S + IgG group. Results are expressed as mean ± SEM (n = 12). *p < 0.05 
vs. C; #p < 0.05 vs. S + IgG group by two-way repeated measures ANOVA for Barnes Maze and one-way ANOVA for open field. Abbreviations: C, control; 
S, surgery.
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and memory by error number in the Barnes maze and detected 
levels of anxiety in the open field. In this test, repeated measures 
ANOVA showed that the error number was significantly affected 
by treatment [F(2,69) = 5.73, p = 0.01], measure time [F(3,69) = 36.79, 
p < 0.001], and the interaction of treatment and measure time 
[F(6,69) =  3.41, p =  0.005]. Compared to the control group, the 
errors of the surgery group treated with control antibodies 
(S +  IgG group) were significantly increased on days 2 and 3 
after surgery, indicating an impairment in learning and memory 
of aged rats after surgery (p = 0.001, respectively) (Figure 1A). 
Compared to the S + IgG group, errors in S + anti-HMGB1 group 
were significantly decreased on days 2 (p =  0.035) and 3 after 
surgery (p = 0.023), denoting a protective effect by perioperative 
anti-HMGB1 treatment (Figure 1A).
In addition, in the open field test, the percentage of square 
crossing in the central area in the S  +  IgG group was sig-
nificantly lower than that of control group on day 3 after surgery 
(7.88 ± 1.74 vs. 16.68 ± 0.79%, p < 0.05) (Figure 1B). Percentage 
square crossing in the central area in S +  anti-HMGB1group 
significantly increased relative to the S + IgG group (16.79 ± 4.53 
vs. 7.88 ± 1.74%, p < 0.05) (Figure 1B).
effects of anti-hMgB1 on Memory  
Marker p-creB
To further investigate the mechanisms of anti-HMGB1 in 
preventing surgery-induced memory decline, we assessed the 
transcription factor CREB, which is closely involved in synaptic 
plasticity and memory function (22). Compared to the control 
group, the level of p-CREB in the DG area of the S + IgG group 
was distinctly decreased on day 3 (13.19 ± 1.05 vs. 2.85 ± 0.43, 
p < 0.05) (Figures 2A,B). Rats treated with anti-HMGB1 mAb 
had significantly higher p-CREB in the DG and CA1 areas than 
the S + IgG group (14.04 ± 0.80 vs. 2.85 ± 0.43 and 9.66 ± 0.47 vs. 
4.68 ± 0.50, p < 0.05, respectively), which was similar to control 
rats (Figures 2B,C).
We also assessed NMDAR expression in hippocampal lysate. 
Compared to control, expression of NMDAR subunits NR2A 
and NR2B was increased at day 3 after surgery (1.00 ± 0.09 vs. 
2.04 ± 0.21 and 1.00 ± 0.04 vs. 1.54 ± 0.08, p < 0.05, respectively) 
(Figures 3A,B). Treatment with anti-HMGB1 mAb significantly 
reduced the upregulation, with levels returning to baseline at day 
3 as compared to the S + IgG group (2.04 ± 0.21 vs. 1.24 ± 0.07 
and 1.54 ± 0.08 vs. 1.09 ± 0.15, p < 0.05, respectively) (Figure 3).
Microglia activation is attenuated by 
anti-hMgB1 Treatment
Neuroinflammation and microglia activation have been impli-
cated in the pathophysiology of cognitive decline (23). Compared 
to control, the percentage of activated microglia, defined by pleo-
morphic and bigger cell body with de-ramification and shorten-
ing of cell processes, was significantly higher in the CA1 and DG 
hippocampal areas after surgery (59.64 ± 2.54 vs. 85.30 ± 0.90 and 
57.23 ± 3.25 vs. 82.25 ± 1.36, p < 0.05, respectively) (Figure 4). 
Notably, treatment with anti-HMGB1 mAb decreased microglia 
activation in CA1 and DG at day 3 after surgery (71.10 ± 3.30 
vs. 85.30 ±  0.90 and 65.92 ±  0.95 vs. 82.25 ±  1.36, p <  0.05, 
respectively) (Figure 4).
Peripheral hMgB1 contributes to 
Postoperative neuroinflammation
To characterize the role of HMGB1 in neuroinflammation after 
surgery, we measured the cellular distribution and expression of 
HMGB1 in the hippocampus. Nuclear translocation of HMGB1 
to the cytoplasm has been reported as a critical pathological 
mechanism in a number of different conditions (24, 25). Notably, 
we found no evident change in cellular localization of HMGB1 in 
the hippocampus after surgery (Figure 5A).
This prompted us to evaluate if peripheral HMGB1 was 
responsible for this neuroinflammatory response. We used 
His-tagged HMGB1 injected into the tail vein of aged rats to 
FigUre 2 | Modulation of p-creB by anti-hMgB1. Representative p-CREB immunofluorescence in the hippocampus, DG and CA1 areas, on postoperative 
day 3 (a). Expression of p-CREB was reduced after surgery (S + IgG), and anti-HMGB1 treatment was effective in rescuing the expression back to levels similar to 
the levels of control animals. (B,c) show relative mean optical density for p-CREB staining in DG and CA1. Results are expressed as mean ± SEM (n = 5). 
Abbreviations: C, control; S, surgery. Scale bar = 50 μm.
FigUre 3 | effects of anti-hMgB1 on nMDar subunits. Expression of NR2A (a) and NR2B (B) was assessed in the hippocampus on day 3. Immunoblots and 
quantifications are shown describing an increase in NR2A and NR2B levels after surgery that was restored almost to baseline by anti-HMGB1 mAb treatment. Results 
are expressed as mean ± SEM (n = 5). *p < 0.05 by one-way ANOVA. Abbreviations: C, control; S, surgery. NR2A/B: N-methyl-d-aspartate receptor subunit 2A/B.
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FigUre 4 | Microglia activation after surgery and effects of anti-hMgB1. Neuroinflammation was assessed by Iba-1 immunofluorescence on postoperative 
day 3. Photomicrographs from DG and CA1 areas of the hippocampus are shown (a). Surgery activated microglia as noted by morphological changes on day 3, 
including enlargement of cell bodies, which was attenuated by anti-HMGB1 mAb treatment. (B,c) show the quantification of Iba-1 immunofluorescence in DG and 
CA1, respectively. Results are expressed as mean ± SEM (n = 5). *p < 0.05 by one-way ANOVA. Abbreviations: C, control; S, surgery. Scale bar = 50 μm.
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detect blood-derived HMGB1 and found a significant increase 
in His-tagged HMGB1 in the hippocampus of both control and 
surgery groups (1.00 ± 0.13 vs. 4.69 ± 0.61 and 5.41 ± 0.95 vs. 
1.10 ± 0.32, p < 0.05, respectively) (Figure 5B) suggesting that 
peripheral HMGB1 could directly enter into the CNS. Plasma 
levels of HMGB1 were significantly increased in aged rats at 
FigUre 5 | expression of hMgB1 in the hippocampus and plasma after surgery. HMGB1 localization in the hippocampus was assessed on postoperative 
day 3 (a). No evident changes regarding nuclear translocation or extracellular HMGB1 were detected after surgery (S + IgG) or in S + anti-HMGB1 groups. Images 
and insets are representative of the hippocampal DG area. We used His-tagged HMGB1 to detect its presence in the CNS after tail vein administration (B). 
Representative immunoblot and quantification show the presence of His-tagged HMGB1 in the hippocampus of both control (C + His-tagged HMGB1) and 
operated rats (S + His-tagged HMGB1). Systemic levels of HMGB1 in rats (c) and human (D) plasma were measured by ELISA on days 1 and 3 after surgery. 
Results are expressed as mean ± SEM. Scale bar = 50 μm.
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days 1 and 3 after surgery (322.20 ± 45.25 vs. 1098.00 ± 82.64 
and 322.20 ± 45.25 vs. 918.30 ± 140.80, p < 0.05, respectively) 
(Figure 5C). We also evaluated human plasma levels of HMGB1 
from patients diagnosed with POD on day 3 and found a sig-
nificant elevation compared to age-matched surgical subjects 
without delirium (627.1 ±  160.2 vs. 1418 ±  258.4, p <  0.05) 
(Figure 5D).
DiscUssiOn
The current study aimed at investigating the role of HMGB1 
signaling after surgery and the therapeutic potential of neutral-
izing anti-HMGB1 mAbs to prevent surgery-induced memory 
dysfunction. Our data indicate a key role for peripherally released 
HMGB1 causing neuroinflammation and memory dysfunction 
after abdominal surgery. Treatment with a neutralizing anti-
HMGB1 mAb reduced microglial activation and prevented 
synaptic plasticity dysfunction. Herein, we uncovered a novel 
mechanism for HMGB1 in regulating p-CREB and synaptic 
plasticity after surgery.
HMGB1 is a multifunctional molecule with a critical role in 
sterile injury, including surgical manipulations (26). Passive and 
active release of HMGB1 may occur after injury: passive release 
occurs instantaneously as a result of disruption of cellular integ-
rity and tissue necrosis; active secretion is a slower process due to 
the interaction with other cellular products (5, 27, 28). Release of 
HMGB1 as well as other DAMPs has been reported after surgery, 
with levels rapidly increasing within 30  min after orthopedic 
injury (10), suggesting that the release of HMGB1 may be critical 
in initiating an inflammatory cascade leading to CNS dysfunc-
tion. Furthermore, increased systemic levels of HMGB1 have 
been reported in elderly patients after gastrointestinal surgery, 
and these levels correlated with the development of POCD (12). 
Vacas et al. (29) showed a single dose of HMGB1 mAb effectively 
reduce circulating levels of HMGB1 and IL-6 after orthopedic 
surgery in younger mice. In our model, we found a more pro-
longed upregulation of systemic HMGB1. This may be related to 
a direct surgical insult to the liver, which contains a large pool 
of HMGB1, and greater cellular senescence promoting age-
associated inflammation (30, 31). Thus, we treated animals twice 
with mAb to prevent both the initial, passive, release of HMGB1 
from the direct tissue trauma, and the secondary increase due to 
the ensuing inflammatory response.
The mechanism whereby peripheral inflammation contrib-
utes to neuroinflammation, neurodegeneration, and cognitive 
dysfunction remains unclear. Intracellular translocation of 
HMGB1 from the nucleus to the cytoplasm is critical for extracel-
lular release by a non-classical secretory mechanism (24, 32). In 
our model, we did not observe evident translocation of HMGB1 
from the nucleus to the cytoplasm in the CNS. The subcellular 
localization of HMGB1 in the studied hippocampal areas after 
surgery was similar to normal expression in the rat brain (33). It 
is possible that the protective effects in our model are mediated 
by an overall dampening of systemic DAMPs and cytokines, 
which in turn prevent endothelial dysfunction and neuroinflam-
mation, and also a direct CNS effect or vagal regulation (34). 
Neuroinflammation has been reported in several models of 
POCD (10, 11, 35), and here we could confirm microglia activa-
tion in the hippocampal formation after surgery. The important 
discovery of the present study is that neuroinflammation was 
reduced by treatment with anti-HMGB1 mAb. Notably, HMGB1 
is necessary and sufficient to trigger memory dysfunction (29), 
microglia activation (36), and prime the immune system (37) 
as demonstrated by administering recombinant HMGB1 in 
otherwise healthy animals. Thus, in POCD models preventing 
systemic HMGB1 increase may be critical in limiting BBB 
opening (11, 38, 39), subsequent monocyte chemoattractant 
protein (MCP-1) expression in the hippocampus (29), micro-
glial activation, and memory deficits. The role of the systemic 
milieu in triggering CNS complications after surgery is further 
demonstrated by the experiments with His-tagged HMGB1, 
suggesting that peripheral HMGB1 can directly access the brain 
parenchyma of aged rats.
In this study, we measured CREB expression in the hip-
pocampus, which is critical in memory and synaptic plasticity 
(22). Phosphorylated CREB was significantly decreased 3 days 
after surgery and treatment with anti-HMGB1 mAb reversed 
this impairment in the hippocampus. Since CREB is implicated 
in hippocampal-dependent memory function and synaptic 
plasticity, the rescuing effect of the anti-HMGB1 mAb treatment 
is consistent with the improved behavioral outcomes demon-
strated in this study. Although we can describe a novel effect 
of anti-HMGB1 mAb to modulate neuroplasticity, the effects of 
peripheral surgery on neuronal function and p-CREB regula-
tion require further elucidation. POCD has been associated with 
changes in synaptic plasticity, including long-term potentiation 
(LTP), and this may be dependent on the neuroinflammatory 
response after trauma (40). In this study, we found changes 
in NMDAR expression after surgery, which was restored by 
anti-HMGB1 mAb treatment. NR2A and NR2B are critical for 
sustaining LTP and are prominently expressed in hippocampal 
pyramidal excitatory cells (41). The increase in NR2A and 
NR2B after surgery may relate to acute neurotoxicity as higher 
expression of NR2A in the hippocampus has been associated 
with poorer cognitive outcomes (42). Furthermore, HMGB1 
has been demonstrated as an excitatory and neurotoxic signal-
ing molecule in the CNS (43) and exerts a prominent role in 
conditions like epilepsy (44).
The anti-inflammatory effects of HMGB1 neutralization have 
been described in several models, including POCD (7–9, 29). 
Here, we provide additional evidence for HMGB1 modulation 
of neuronal molecules of relevance to synaptic plasticity and 
memory function.
In the present study, we have not determined the redox states 
of HMGB1. This is critical to a better understating of the role 
of HMGB1 signaling after trauma as posttranslational modifica-
tions regulate receptor usage and thus functionality (45). The 
HMGB1-receptors TLR4 and RAGE have been demonstrated 
to be upregulated in POCD models (11, 35). No HMGB1 
redox isoform restriction is known for RAGE signaling, while 
disulfide-HMGB1 is required for interaction with TLR4 and 
TLR4-mediated neuroinflammation and disruption of memory-
related signaling in the hippocampus. Moreover, TLR4 activation 
modulates NMDAR subunits through HMGB1 signaling (46), 
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